February 27, 2025

Harmony Biosciences provides updates on WAKIX, pitolisant HD, pitolisant GR, and an orexin-2 receptor agonist. In a press release issued this month, Jeffrey M. Dayno, MD, president and CEO of Harmony Biosciences Holdings Inc, says, “2025 is set up to be a transformational year for Harmony, as our robust, late-stage pipeline comes into focus and…

Summary: A new study reveals that even a single night of sleep deprivation can alter immune cell profiles to resemble those seen in obesity, potentially increasing inflammation and the risk of chronic diseases like diabetes and cardiovascular conditions. Key Takeaways:  A single night of sleep deprivation can alter immune cell profiles, making them resemble those…